Recursion Pharmaceuticals’s stock price closed at $5.00. It is down -6.72% in the last 3 months and down -28.26% in the last 12 months. Recursion Pharmaceuticals saw 0 positive EPS revisions and 4 ...

We recently published 12 Best Healthcare Stocks to Buy Under $30. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best healthcare stocks. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a ...

Investors sold out of the biotech following a quarterly earnings release this morning. The company posted a deeper-than-expected net loss. For its second quarter, Recursion earned $19.2 million in ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $5.27, marking a +1.15% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.83%. At ...

The most recent trading session ended with Recursion Pharmaceuticals (RXRX) standing at $5.84, reflecting a +1.83% shift from the previouse trading day's closing. The stock outpaced the S&P 500's ...

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Python has emerged as one of the most popular programming languages due to its simplicity, versatility, and robust ecosystem. When it comes to web development, Django stands out as a powerful, ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) and Exscientia plc is fair to Recursion ...